BIOMARIN PHARMACEUTICAL INC (BMRN) — institutional ownership
601 funds reported holding BIOMARIN PHARMACEUTICAL INC in their latest 13F filings, worth $13.5B in total (CUSIP 09061G101).
Largest holders
- BlackRock, Inc. (BLK) — $1.17B
- VANGUARD GROUP INC — $1.08B
- Banque Cantonale Vaudoise — $916M
- DODGE & COX — $849M
- PRIMECAP MANAGEMENT CO/CA/ — $812M
- VANGUARD CAPITAL MANAGEMENT LLC — $500M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $495M
- NORGES BANK — $470M
- STATE STREET CORP (STT, STT-PG) — $446M
- VIKING GLOBAL INVESTORS LP — $436M
Famous investors holding it
- Andreas Halvorsen portfolio (Viking Global Investors)
- Izzy Englander portfolio (Millennium Management)
- Ken Griffin portfolio (Citadel Advisors)
- Renaissance Technologies portfolio (Renaissance Technologies)
- Ray Dalio portfolio (Bridgewater Associates)
- D. E. Shaw portfolio (D. E. Shaw & Co.)
- Two Sigma portfolio (Two Sigma Investments)
Insider buying and selling at BIOMARIN PHARMACEUTICAL INC
Who owns the most BMRN stock?
The largest institutional holders in the latest 13F filings are BlackRock, Inc. (BLK) ($1.17B), VANGUARD GROUP INC ($1.08B), Banque Cantonale Vaudoise ($916M).
How many funds own BMRN?
601 funds reported holding it, worth $13.5B in total.